At a glance
- Originator Nonindustrial source
- Class Anxiolytics
- Mechanism of Action Cholecystokinin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Anxiety disorders in Spain (Unknown route)
- 23 Sep 1997 Preclinical development for Anxiety disorders in Spain (Unknown route)